Sarka Pavlova

9PUBLICATIONS
86CO-AUTHORS
Cancer geneticsEpigenetics (incl. genome methylation and epigenomics)Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Immunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Sep 24, 2026
In-frame variants in TP53 gene identified in adult leukemia samples are predominantly deleterious: a study of the TP53 Network of Education and Research Initiative on CLL.

|Jan 22, 2025
Detection of clinically relevant variants in the TP53 gene below 10% allelic frequency: A multicenter study by ERIC, the European Research Initiative on CLL.

Sarka Pavlova, Jitka Malcikova, Lenka Radova

|Dec 04, 2024
Dysregulation of the p53 pathway provides a therapeutic target in aggressive pediatric sarcomas with stem-like traits.

Lucie Curylova, Iva Staniczkova Zambo, Jakub Neradil

|Jul 22, 2024
Realizing precision medicine in chronic lymphocytic leukemia: Remaining challenges and potential opportunities.

Kostas Stamatopoulos, Sarka Pavlova, Othman Al-Sawaf

|May 21, 2024
Unveiling the dynamics and molecular landscape of a rare chronic lymphocytic leukemia subpopulation driving refractoriness: insights from single-cell RNA sequencing.

Terezia Kurucova, Kamila Reblova, Pavlina Janovska

|May 16, 2024
ERIC recommendations for TP53 mutation analysis in chronic lymphocytic leukemia-2024 update.

Jitka Malcikova, Sarka Pavlova, Panagiotis Baliakas

Pageof 2

Frequent Collaborators

7 joint publications

Sarka Pospisilova

6 joint publications

Jitka Malcikova

5 joint publications

Michael Doubek

4 joint publications

Karla Plevova